Charles River Laboratories International (CRL) EV to EBITDA (2010 - 2026)
Charles River Laboratories International's (CRL) EV to EBITDA stood at 26.15 in Q2 2026, up 100.4% from 13.05 a year earlier and up 46.3% from the prior quarter.
Powered by 
Analysis
Charles River Laboratories International (CRL) EV to EBITDA (2010 - 2026) Analysis & Trends
On a TTM basis, Charles River Laboratories International's EV to EBITDA came in at 24.57 as of Jun 27, 2026, up 106.4% year-over-year; for FY2025, it came in at 22.99, up 44.6% from FY2024.
- Annual EV to EBITDA has increased for three straight years.
- Across earlier years, EV to EBITDA came in at 15.90 in FY2024 (+24.3%), 12.79 in FY2023 (+12.0%), 11.43 in FY2022 (-47.0%) and 21.57 in FY2021 (+16.8%).
- The Q2 2026 figure is the highest quarterly EV to EBITDA since Q3 2021.
- On a year-over-year basis, EV to EBITDA has increased for five consecutive quarters, with growth averaging 27.9% over the last eight quarters.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 100.4% in Q2 2026, against a decline of 65.5% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 17.88 (Q1 2026), 22.99 (Q4 2025) and 12.58 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.30 Bn | 36.13 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.36 Bn | 15.43 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 14.14 Bn | 13.38 Bn | 363.37 Mn |
| 4 | Icon | 13.04 Bn | 10.15 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.88 Bn | 1.26 Bn | 139.20 Mn |
| 6 | Ginkgo Bioworks Holdings | 762.62 Mn | 537,907.95 | 18.44 Mn |
| 7 | Evotec SE | 583.11 Mn | -990.11 Mn | - |
| 8 | Champions Oncology | 68.48 Mn | 44.13 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 64.46 Mn | 28.68 Mn | 1.61 Mn |
| 10 | Natural Alternatives International | 8.86 Mn | -19.22 Mn | 1.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 26.15 |
| Mar 28, 2026 | 17.88 |
| Dec 27, 2025 | 22.99 |
| Sep 27, 2025 | 12.58 |
| Jun 28, 2025 | 13.05 |
| Mar 29, 2025 | 13.01 |
| Dec 28, 2024 | 15.90 |
| Sep 28, 2024 | 11.49 |
| Jun 29, 2024 | 11.79 |
| Mar 30, 2024 | 15.25 |
| Dec 30, 2023 | 12.79 |
| Sep 30, 2023 | 10.36 |
| Jul 1, 2023 | 11.13 |
| Apr 1, 2023 | 10.42 |
| Dec 31, 2022 | 11.43 |
| Sep 24, 2022 | 9.84 |
| Jun 25, 2022 | 11.92 |
| Mar 26, 2022 | 15.65 |
| Dec 25, 2021 | 21.57 |
| Sep 25, 2021 | 28.50 |
API Access
Charles River Laboratories International EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CRL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "CRL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CRL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();